In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of CorMedix Inc (NASDAQ: CRMD) was $9.90 for the day, up 0.41% from the previous closing price of $9.86. In other words, the price has increased by $0.41 from its previous closing price. On the day, 0.89 million shares were traded. CRMD stock price reached its highest trading level at $10.07 during the session, while it also had its lowest trading level at $9.64.
Ratios:
Our analysis of CRMD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 26, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.Needham initiated its Buy rating on February 17, 2021, with a $31 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 14 ’24 when Hurlburt Elizabeth sold 140,027 shares for $11.18 per share. The transaction valued at 1,565,670 led to the insider holds 45,397 shares of the business.
Hurlburt Elizabeth bought 140,027 shares of CRMD for $1,556,416 on Nov 14 ’24. On Mar 13 ’24, another insider, Todisco Joseph, who serves as the Chief Executive Officer of the company, bought 13,561 shares for $3.74 each. As a result, the insider paid 50,718 and bolstered with 352,839 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 600704256 and an Enterprise Value of 555231232. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.41 while its Price-to-Book (P/B) ratio in mrq is 9.76. Its current Enterprise Value per Revenue stands at 45.28 whereas that against EBITDA is -10.937.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $2.89. The 50-Day Moving Average of the stock is -2.96%, while the 200-Day Moving Average is calculated to be 60.17%.
Shares Statistics:
CRMD traded an average of 1.19M shares per day over the past three months and 969490 shares per day over the past ten days. A total of 60.68M shares are outstanding, with a floating share count of 59.76M. Insiders hold about 1.51% of the company’s shares, while institutions hold 31.38% stake in the company. Shares short for CRMD as of 1731628800 were 6840218 with a Short Ratio of 5.77, compared to 1728950400 on 7860576. Therefore, it implies a Short% of Shares Outstanding of 6840218 and a Short% of Float of 11.2799995.
